James O’Brien's Insider Trades & SAST Disclosures
James O’Brien's most recent trade in LQR House Inc was a trade of 780 Common Stock done . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James O’Brien.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LQR House Inc | James O’Brien | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 780 | 780 | - | 0 | Common Stock | |
| LQR House Inc | James O’Brien | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 780 | 470 | - | - | Restricted Stock Units | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 277 | 15,640 | - | - | Phantom Stock Units | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,750 | 5,313 (0%) | 0% | 0 | Common Stock | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10 | 5,323 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,252 | 3,803 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 303 | 15,131 | - | - | Phantom Stock Units | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 408 | 14,547 | - | - | Phantom Stock Units | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 750 | 3,563 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 1,396 | 2,551 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 369 | 13,855 | - | - | Phantom Stock Units | |
| Humana Inc. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 1,794 (0%) | 0% | 0 | Humana Common | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2022 | 417 | 13,299 | - | - | Phantom Stock Units | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 731 | 2,813 (0%) | 0% | 0 | Common Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 1,041 | 12,523 | - | - | Phantom Stock Units | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 270 | 11,467 | - | - | Phantom Stock Units | |
| Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Humana Inc. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 412 | 1,414 (0%) | 0% | 0 | Humana Common | |
| Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 13 Oct 2021 | 5,000 | 5,000 | - | 12 | 60,000 | Common Stock |
| Cognition Therapeutics Inc | James M. O’Brien | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 54,457 | 54,457 | - | - | Stock Option (right to buy) | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 294 | 11,084 | - | - | Phantom Stock Units | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 15,003 | - | - | Phantom Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 807 | 10,591 | - | - | Phantom Stock Units | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 270 | 9,801 | - | - | Phantom Stock Units | |
| Humana Inc. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 403 | 1,002 (0%) | 0% | 0 | Humana Common | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 384 | 9,296 | - | - | Phantom Stock Units | |
| Albemarle Corp. | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 1,725 | 13,999 | - | - | Phantom Stock | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2020 | 1,654 | 8,906 | - | - | Phantom Stock Units | |
| Eastman Chemical Co | James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 668 | 7,290 | - | - | Phantom Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges